VistaGen Therapeutics(VTGN)
$0.18+0.00 (+2.22%)
VTGN
VistaGen Therapeutics earnings date
$0.18
At close:+0.00 (+2.22%)
Want to see VTGN full AI Analyst Report?
VistaGen Therapeutics (VTGN) Q3 2022 Earnings Report
1,155 Followers
VTGN Q3 2022 EPS Results
- Actual EPS
- -$1.50
- Consensus EPS
- -$2.18
- Beat/Miss
- Beat by +$0.67
- One Year Ago EPS
- -$2.10
VTGN Q3 2022 Revenue Results
- Actual Revenue
- $357.90K
- Expected Revenue
- $339.00K
- Beat/Miss
- Beat by +$18.90K
- YoY Revenue Growth
- +14.13%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 02/10/2022
- Time
- After Close
- Conference Call
- Thursday, February 10, 2022
VTGN Upcoming Earnings
VistaGen Therapeutics's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
VTGN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 11, 2027 | 2027 (Q3) | -0.32- | -0.45 | ― | ― |
| Nov 13, 2026 | 2027 (Q2) | -0.38-0.24 | -0.54 | 55.56% (+0.30) | |
| Aug 14, 2026 | 2027 (Q1) | -0.36-0.30 | -0.47 | 36.17% (+0.17) | |
| Jun 15, 2026 | 2026 (Q4) | -0.34-0.37 | -0.43 | 13.95% (+0.06) | |
| Feb 12, 2026 | 2026 (Q3) | -0.49-0.45 | -0.46 | 2.17% (+0.01) | |
| Nov 13, 2025 | 2026 (Q2) | -0.48-0.54 | -0.42 | -28.57% (-0.12) | |
| Aug 07, 2025 | 2026 (Q1) | -0.47-0.47 | -0.35 | -34.29% (-0.12) | |
| Jun 17, 2025 | 2025 (Q4) | -0.50-0.43 | 0.3 | -243.33% (-0.73) | |
| Feb 13, 2025 | 2025 (Q3) | -0.51-0.46 | -0.22 | -109.09% (-0.24) | |
| Nov 07, 2024 | 2025 (Q2) | -0.39-0.42 | -0.66 | 36.36% (+0.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

